Form 4: Septerna CPO Executes Stock Option Exercise and Sale

Chief People Officer Samira Shaikhly exercised options for 11,798 shares of Septerna, Inc. and subsequently sold them under a Rule 10b5-1 plan.

Summary

• Samira Shaikhly, Chief People Officer of Septerna, Inc., exercised stock options for 11,798 shares at a strike price of $6.81.
• Following the exercise, the reporting person sold the 11,798 shares at a weighted average price of $30.0607 per share.
• The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on October 31, 2025.
• Post-transaction, the reporting person retains 793 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; it is a routine insider transaction executed under a pre-established plan, which is standard for executive compensation.

Positives

• The transaction was pre-planned under a Rule 10b5-1 plan, indicating a structured approach to liquidity rather than reactive selling.
• The exercise price of $6.81 compared to the sale price of approximately $30.06 reflects significant value appreciation for the executive.

Negatives

• The executive reduced their direct beneficial ownership of common stock to 793 shares following the sale.

Risks

• Future sales by insiders may occur as part of ongoing Rule 10b5-1 plans, which could influence market sentiment regarding the stock.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via Rule 10b5-1 plans is a standard practice in the biotechnology sector, allowing executives to diversify holdings while avoiding concerns regarding non-public information.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is consistent with best practices for corporate governance among publicly traded biotech firms.
• The volume of shares sold is relatively small compared to total outstanding shares, typical for executive compensation liquidity events.

Stakeholder Impact

• Minimal impact on shareholders as the sale was conducted via a pre-planned 10b5-1 arrangement.

Next Steps

• The reporting person continues to hold 793 shares of common stock.

Key Dates

Keywords

Septerna, SEPN, Insider Trading, Form 4, Stock Options, Biotech